SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 13.73 |
| Enterprise Value ($M) | 2.61 |
| Book Value ($M) | 14.48 |
| Book Value / Share | 0.18 |
| Price / Book | 0.95 |
| NCAV ($M) | 6.11 |
| NCAV / Share | 0.08 |
| Price / NCAV | 2.25 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.56 |
| Return on Assets (ROA) | -1.19 |
| Return on Equity (ROE) | -1.74 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.08 |
| Current Ratio | 4.08 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 12.58 |
| Assets | 20.94 |
| Liabilities | 6.47 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -29.60 |
| Net Income | -30.44 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -24.15 |
| Cash from Investing | -0.19 |
| Cash from Financing | 14.18 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Ho William Tai-Wei | 5.60 | 31.10 | |
| 13G | Alyeska Investment Group, L.P. | 9.90 | ||
| 13G/A | Hirschman Orin | 8.50 | -8.10 | |
| 13D/A | BIOS Fund II, LP | 23.10 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| tm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 100,151 | 768,983 | 13.02 | |
| 105,054 | 391,995 | 26.80 | |
| 86,205 | 721,580 | 11.95 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| IMNM – Immunome, Inc. | IMNN – Imunon, Inc. |
| IMTX – Immatics N.V. | INDP – Indaptus Therapeutics, Inc. |
| INKT – MiNK Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io